On July 3rd UPyTher received the prestigious Gerard & Anton Award as 'One to Watch' startup company in the Brainport Region.

Helmuth brings over 30 years of experience in the biotech industry. His addition to the team will boost the growth of UPyTher and advancement of the company's lead product UPT-211 to the clinical stage.

The seed funding supports preclinical development of UPyTher's lead product UPT-211.

Funding from Europe and the Province of North Brabant for Eindhoven based comapnies UPyTher and SupraPolix BV to bring a novel and improved therapy to patients with peritoneal cancer, with a total budget of EUR 2.8 million.